Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 477

1.

The history of Transcatheter Aortic Valve Implantation (TAVI)-A personal view over 25 years of development.

Figulla HR, Franz M, Lauten A.

Cardiovasc Revasc Med. 2019 Jun 12. pii: S1553-8389(19)30323-9. doi: 10.1016/j.carrev.2019.05.024. [Epub ahead of print] Review.

PMID:
31383557
2.

Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI).

Muessig JM, Lichtenauer M, Wernly B, Kelm M, Franz M, Bäz L, Schulze PC, Racher V, Zimmermann G, Figulla HR, Paar V, Hoppe UC, Rouet P, Lauten A, Jung C.

Int J Cardiol. 2019 Feb 15;277:54-59. doi: 10.1016/j.ijcard.2018.09.091. Epub 2018 Oct 2.

PMID:
30309683
3.

Efficacy of temperature-guided cryoballoon ablation without using real-time recordings - 12-Month follow-up.

Prochnau D, von Knorre K, Figulla HR, Schulze PC, Surber R.

Int J Cardiol Heart Vasc. 2018 Oct 4;21:50-55. doi: 10.1016/j.ijcha.2018.09.009. eCollection 2018 Dec.

4.

Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI).

Mirna M, Wernly B, Paar V, Jung C, Jirak P, Figulla HR, Kretzschmar D, Franz M, Hoppe UC, Lichtenauer M, Lauten A.

Biomarkers. 2018 Dec;23(8):773-780. doi: 10.1080/1354750X.2018.1499127. Epub 2018 Aug 31.

PMID:
30041555
5.

Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.

Alushi B, Beckhoff F, Leistner D, Franz M, Reinthaler M, Stähli BE, Morguet A, Figulla HR, Doenst T, Maisano F, Falk V, Landmesser U, Lauten A.

JACC Cardiovasc Imaging. 2019 Apr;12(4):591-601. doi: 10.1016/j.jcmg.2018.02.015. Epub 2018 Apr 18.

PMID:
29680341
6.

Caval Valve Implantation for Treatment of Severe Tricuspid Regurgitation.

Lauten A, Dreger H, Schofer J, Grube E, Beckhoff F, Jakob P, Sinning JM, Stangl K, Figulla HR, Laule M.

J Am Coll Cardiol. 2018 Mar 13;71(10):1183-1184. doi: 10.1016/j.jacc.2017.12.056. No abstract available.

7.

Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study.

Lauten A, Figulla HR, Unbehaun A, Fam N, Schofer J, Doenst T, Hausleiter J, Franz M, Jung C, Dreger H, Leistner D, Alushi B, Stundl A, Landmesser U, Falk V, Stangl K, Laule M.

Circ Cardiovasc Interv. 2018 Feb;11(2):e006061. doi: 10.1161/CIRCINTERVENTIONS.117.006061.

PMID:
29445001
8.

Caval Valve Implantation.

Lauten A, Dreger H, Laule M, Stangl K, Figulla HR.

Interv Cardiol Clin. 2018 Jan;7(1):57-63. doi: 10.1016/j.iccl.2017.08.008. Epub 2017 Oct 12. Review.

PMID:
29157524
9.

Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction.

Schernthaner C, Paar V, Wernly B, Pistulli R, Rohm I, Jung C, Figulla HR, Yilmaz A, Cadamuro J, Haschke-Becher E, Schulze PC, Hoppe UC, Lichtenauer M, Kretzschmar D.

Medicine (Baltimore). 2017 Nov;96(44):e8396. doi: 10.1097/MD.0000000000008396.

10.

Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis.

Katte F, Franz M, Jung C, Figulla HR, Leistner D, Jakob P, Stähli BE, Kretzschmar D, Lauten A.

EuroIntervention. 2018 Feb 20;13(14):1635-1644. doi: 10.4244/EIJ-D-17-00476.

11.

Impact of Moderate Altitude on Pro-Inflammatory Cytokines in Healthy Volunteers.

Edlinger C, Schreiber C, Goebel B, Pistulli R, Paar V, Schernthaner C, Rohm I, Figulla HR, Hoppe UC, Franz M, Jung C, Lichtenauer M.

Clin Lab. 2017 Sep 1;63(9):1545-1548. doi: 10.7754/Clin.Lab.2017.170321.

PMID:
28879713
12.

Multibiomarker analysis in patients with acute myocardial infarction.

Schernthaner C, Lichtenauer M, Wernly B, Paar V, Pistulli R, Rohm I, Jung C, Figulla HR, Yilmaz A, Cadamuro J, Haschke-Becher E, Pernow J, Schulze PC, Hoppe UC, Kretzschmar D.

Eur J Clin Invest. 2017 Sep;47(9):638-648. doi: 10.1111/eci.12785. Epub 2017 Jul 28.

PMID:
28683166
13.

Acute effects of moderate altitude on biomarkers of cardiovascular inflammation and endothelial function and their differential modulation by dual endothelin receptor blockade.

Lichtenauer M, Goebel B, Paar V, Wernly B, Gecks T, Rohm I, Förster M, Betge S, Figulla HR, Hoppe UC, Kelm M, Franz M, Jung C.

Clin Hemorheol Microcirc. 2017;67(1):101-113. doi: 10.3233/CH-170273.

PMID:
28550241
14.

Vena contracta area for severity grading in functional and degenerative mitral regurgitation: a transoesophageal 3D colour Doppler analysis in 500 patients.

Goebel B, Heck R, Hamadanchi A, Otto S, Doenst T, Jung C, Lauten A, Figulla HR, Schulze PC, Poerner TC.

Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):639-646. doi: 10.1093/ehjci/jex056.

PMID:
28444164
15.

Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI.

Otto S, Nitsche K, Jung C, Kryvanos A, Zhylka A, Heitkamp K, Gutiérrez-Chico JL, Goebel B, Schulze PC, Figulla HR, Poerner TC.

BMC Cardiovasc Disord. 2017 Apr 26;17(1):103. doi: 10.1186/s12872-017-0534-1.

16.

Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation.

Wernly B, Lichtenauer M, Jirak P, Eder S, Reiter C, Kammler J, Kypta A, Jung C, Franz M, Hoppe UC, Landmesser U, Figulla HR, Lauten A.

Eur J Clin Invest. 2017 Feb;47(2):149-157. doi: 10.1111/eci.12719.

PMID:
28036122
17.

Quality of Life After Transcatheter Aortic Valve Replacement: Prospective Data From GARY (German Aortic Valve Registry).

Lange R, Beckmann A, Neumann T, Krane M, Deutsch MA, Landwehr S, Kötting J, Welz A, Zahn R, Cremer J, Figulla HR, Schuler G, Holzhey DM, Funkat AK, Heusch G, Sack S, Pasic M, Meinertz T, Walther T, Kuck KH, Beyersdorf F, Böhm M, Möllmann H, Hamm CW, Mohr FW; GARY Executive Board.

JACC Cardiovasc Interv. 2016 Dec 26;9(24):2541-2554. doi: 10.1016/j.jcin.2016.09.050.

18.

Interventional left atrial appendage occlusion: added value of 3D transesophageal echocardiography for device sizing.

Goebel B, Wieg S, Hamadanchi A, Otto S, Jung C, Kretzschmar D, Figulla HR, Christian Schulze P, Poerner TC.

Int J Cardiovasc Imaging. 2016 Sep;32(9):1363-1370. Epub 2016 Jun 6.

PMID:
27271934
19.

Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.

Figulla HR, Kiss K, Lauten A.

EuroIntervention. 2016 Sep 18;12(Y):Y116-8. doi: 10.4244/EIJV12SYA32. Review. No abstract available.

20.

Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.

Ziffels B, Ospel J, Grün K, Neri D, Pfeil A, Fritzenwanger M, Figulla HR, Jung C, Berndt A, Franz M.

Dis Markers. 2016;2016:3695454. doi: 10.1155/2016/3695454. Epub 2016 Aug 18.

21.

A novel polymer-free ciglitazone-coated vascular stent: in vivo and ex vivo analysis of stent endothelialization in a rabbit iliac artery model.

Otto S, Jaeger K, Kolodgie FD, Muehlstaedt D, Franz M, Bischoff S, Schubert H, Figulla HR, Virmani R, Poerner TC.

Oncotarget. 2016 Sep 6;7(36):57571-57580. doi: 10.18632/oncotarget.11584.

22.

Alterations in systemic levels of Th1, Th2, and Th17 cytokines in overweight adolescents and obese mice.

Jung C, Lichtenauer M, Strodthoff D, Winkels H, Wernly B, Bürger C, Kamchybekov U, Lutgens E, Figulla HR, Gerdes N.

Pediatr Diabetes. 2017 Dec;18(8):714-721. doi: 10.1111/pedi.12435. Epub 2016 Sep 6.

PMID:
27597513
23.

Resistant hypertension: Comparison of unifocal versus multifocal radiofrequency ablation for renal denervation up to 24months follow-up.

Prochnau D, Schweizer C, Hoyme M, Figulla HR, Schulze PC, Surber R.

Int J Cardiol. 2016 Nov 15;223:31-33. doi: 10.1016/j.ijcard.2016.08.192. Epub 2016 Aug 9. No abstract available.

PMID:
27529585
24.

Pulse contour cardiac output monitoring in acute heart failure patients : Assessment of hemodynamic measurements.

Wernly B, Lichtenauer M, Franz M, Fritzenwanger M, Kabisch B, Figulla HR, Jung C.

Wien Klin Wochenschr. 2016 Dec;128(23-24):864-869. Epub 2016 Aug 15.

25.

Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI).

Jung C, Lichtenauer M, Figulla HR, Wernly B, Goebel B, Foerster M, Edlinger C, Lauten A.

Heart Vessels. 2017 Apr;32(4):458-466. doi: 10.1007/s00380-016-0885-z. Epub 2016 Aug 3.

26.

Predictive value of the augmentation index derived vascular age in patients with newly diagnosed atherosclerosis.

Betge S, Kretzschmar D, Figulla HR, Lichtenauer M, Jung C.

Heart Vessels. 2017 Mar;32(3):252-259. doi: 10.1007/s00380-016-0868-0. Epub 2016 Jul 11.

27.

Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.

Poerner TC, Duderstadt C, Goebel B, Kretzschmar D, Figulla HR, Otto S.

Clin Res Cardiol. 2017 Jan;106(1):18-27. doi: 10.1007/s00392-016-1019-4. Epub 2016 Jul 5.

28.

Effect of endothelin-1 and endothelin receptor blockade on the release of microparticles.

Jung C, Lichtenauer M, Wernly B, Franz M, Goebel B, Rafnsson A, Figulla HR, Pernow J.

Eur J Clin Invest. 2016 Aug;46(8):707-13. doi: 10.1111/eci.12652. Epub 2016 Jul 11.

PMID:
27322814
29.

Renal denervation with standard radiofrequency ablation catheter is effective in 24-hour ambulatory blood pressure reduction - follow-up at 1/3/6/12 months.

Prochnau D, Otto S, Figulla HR, Surber R.

Neth Heart J. 2016 Jul;24(7-8):449-55. doi: 10.1007/s12471-016-0839-1.

30.

The transcatheter valve technology pipeline for treatment of adult valvular heart disease.

Figulla HR, Webb JG, Lauten A, Feldman T.

Eur Heart J. 2016 Jul 21;37(28):2226-39. doi: 10.1093/eurheartj/ehw153. Epub 2016 May 8. Review.

PMID:
27161617
31.

Decrease of circulating myeloid dendritic cells in patients with chronic heart failure.

Pistulli R, Hammer N, Rohm I, Kretzschmar D, Jung C, Figulla HR, Yilmaz A.

Acta Cardiol. 2016 Apr;71(2):165-72. doi: 10.2143/AC.71.2.3141846.

PMID:
27090038
32.

Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: Implementation of a three-dimensional analysis algorithm with optical coherence tomography.

Otto S, Gassdorf J, Nitsche K, Gutiérrez-Chico JL, Kryvanos A, Goebel B, Figulla HR, Poerner TC.

Cardiol J. 2016;23(3):296-306. doi: 10.5603/CJ.a2016.0018. Epub 2016 Apr 11.

33.

[Medical and interventional treatment of right heart failure].

Horn P, Westenfeld R, Figulla HR.

Dtsch Med Wochenschr. 2016 Apr;141(7):478-80. doi: 10.1055/s-0041-111257. Epub 2016 Mar 31. German.

PMID:
27031201
34.

Hypobaric hypoxia in 3000 m altitude leads to a significant decrease in circulating plasmacytoid dendritic cells in humans.

Rohm I, Aderhold N, Ratka J, Goebel B, Franz M, Pistulli R, Gecks T, Figulla HR, Yilmaz A, Jung C.

Clin Hemorheol Microcirc. 2016 Sep 12;63(3):257-65. doi: 10.3233/CH-152035.

PMID:
26890107
35.

Current Results of Surgical Aortic Valve Replacement: Insights From the German Aortic Valve Registry.

Holzhey D, Mohr FW, Walther T, Möllmann H, Beckmann A, Kötting J, Figulla HR, Cremer J, Kuck KH, Lange R, Sack S, Schuler G, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW.

Ann Thorac Surg. 2016 Feb;101(2):658-66. doi: 10.1016/j.athoracsur.2015.07.090. Epub 2015 Nov 11.

PMID:
26576751
36.

Involvement of phosphoinositide 3-kinase class IA (PI3K 110α) and NADPH oxidase 1 (NOX1) in regulation of vascular differentiation induced by vascular endothelial growth factor (VEGF) in mouse embryonic stem cells.

Bekhite MM, Müller V, Tröger SH, Müller JP, Figulla HR, Sauer H, Wartenberg M.

Cell Tissue Res. 2016 Apr;364(1):159-74. doi: 10.1007/s00441-015-2303-8. Epub 2015 Nov 9.

PMID:
26553657
37.

Intravital microscopy - A novel tool in characterizing congestive heart failure in experimental autoimmune myocarditis.

Pistulli R, Quitter F, Andreas E, Rohm I, Kretzschmar D, Figulla HR, Yilmaz A, Jung C.

Clin Hemorheol Microcirc. 2015 Oct 16;63(2):153-62. doi: 10.3233/CH-152015.

PMID:
26484717
38.

Impact of Systemic Normobaric Short-Term Hypoxia on Pro-Inflammatory and Anti-Inflammatory Cytokines in Healthy Volunteers.

Rohm I, Ratka J, Pistulli R, Goebel B, Gecks T, Figulla HR, Yilmaz A, Jung C.

Clin Lab. 2015;61(8):1053-9.

PMID:
26427151
39.

The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud's phenomenon as detected by functional imaging.

Jung C, Drummer K, Oelzner P, Figulla HR, Boettcher J, Franz M, Betge S, Foerster M, Wolf G, Pfeil A.

Clin Hemorheol Microcirc. 2015;61(3):549-57. doi: 10.3233/CH-151956.

PMID:
26410864
40.

Development and characterization of an ex vivo arterial long-term proliferation model for restenosis research.

Haase D, Otto S, Romeike BFM, Figulla HR, Poerner TC.

ALTEX. 2015;32(4):307-317. doi: 10.14573/altex.1503051. Epub 2015 Sep 24.

41.

Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP.

Mazrouei S, Sharifpanah F, Bekhite MM, Figulla HR, Sauer H, Wartenberg M.

Purinergic Signal. 2015 Dec;11(4):491-506. doi: 10.1007/s11302-015-9468-1. Epub 2015 Sep 22.

42.

Tricuspid valve interventions in 2015.

Lauten A, Figulla HR.

EuroIntervention. 2015 Sep;11 Suppl W:W133-6. doi: 10.4244/EIJV11SWA37. Review.

43.

Impact of diabetes mellitus and its complications: survival and quality-of-life in critically ill patients.

Bannier K, Lichtenauer M, Franz M, Fritzenwanger M, Kabisch B, Figulla HR, Pfeifer R, Jung C.

J Diabetes Complications. 2015 Nov-Dec;29(8):1130-5. doi: 10.1016/j.jdiacomp.2015.08.010. Epub 2015 Aug 15.

PMID:
26361811
44.

Outcome predictors in cardiopulmonary resuscitation facilitated by extracorporeal membrane oxygenation.

Jung C, Janssen K, Kaluza M, Fuernau G, Poerner TC, Fritzenwanger M, Pfeifer R, Thiele H, Figulla HR.

Clin Res Cardiol. 2016 Mar;105(3):196-205. doi: 10.1007/s00392-015-0906-4. Epub 2015 Aug 25.

PMID:
26303097
45.

Red cell distribution width and survival in patients hospitalized on a medical ICU.

Fujita B, Franz M, Figulla HR, Pfeifer R, Kabisch B, Fritzenwanger M, Jung C.

Clin Biochem. 2015 Nov;48(16-17):1048-52. doi: 10.1016/j.clinbiochem.2015.07.011. Epub 2015 Jul 10.

PMID:
26169241
46.

[Interventions at the tricuspid valve: What is possible?].

Lauten A, Figulla HR.

Herz. 2015 Aug;40(5):759-64. doi: 10.1007/s00059-015-4332-1. Review. German.

PMID:
26135466
47.

Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.

Franz M, Doll F, Grün K, Richter P, Köse N, Ziffels B, Schubert H, Figulla HR, Jung C, Gummert J, Renner A, Neri D, Berndt A.

Int J Cardiol. 2015 Sep 15;195:311-22. doi: 10.1016/j.ijcard.2015.05.144. Epub 2015 May 29.

PMID:
26056964
48.

Triple transcatheter and surgical valve replacement: a 'hybrid' approach to valvular heart disease.

Lauten A, Doenst T, Figulla HR.

Eur Heart J. 2016 Mar 7;37(10):853. doi: 10.1093/eurheartj/ehv241. Epub 2015 Jun 3. No abstract available.

PMID:
26040802
49.

Decrease in circulating dendritic cell precursors in patients with peripheral artery disease.

Kretzschmar D, Rohm I, Schäller S, Betge S, Pistulli R, Atiskova Y, Figulla HR, Yilmaz A.

Mediators Inflamm. 2015;2015:450957. doi: 10.1155/2015/450957. Epub 2015 Apr 15.

50.

[Interventional therapy of heart valve diseases: future perspectives].

Figulla HR, Lauten A.

Herz. 2015 Apr;40(2):215-23. doi: 10.1007/s00059-015-4207-5. Review. German.

PMID:
25822420

Supplemental Content

Loading ...
Support Center